共 50 条
- [1] Pooled Safety Analysis of Quizartinib Monotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)BLOOD, 2019, 134Cortes, Jorge E.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAGanguly, Siddhartha论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas Hlth Syst, Kansas City, KS USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKraemer, Alwin论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, Clin Cooperat Unit Mol Hematol Oncol, Heidelberg, Germany German Canc Res Ctr, Heidelberg, Germany Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USALevis, Mark J.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAMartinelli, Giovanni论文数: 0 引用数: 0 h-index: 0机构: Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, FC, Italy Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAPerl, Alexander E.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USARussell, Nigel H.论文数: 0 引用数: 0 h-index: 0机构: Nottingham Univ Hosp, Nottingham, England Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAChoi, Youngsook论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAMendell, Jeanne论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USANamuyinga, Ruth论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAHoang Pham论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USASaid, Nabil论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAWang, Yibin论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAMitov, Tsvetomir论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo UK Ltd, Gerrards Cross, England Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKim, Ben论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKhaled, Samer K.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, Duarte, CA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
- [2] A Phase IB/II Study of Lirilumab with Azacytidine in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S6 - S7Daver, Naval论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABoddu, Prajwal论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USARavandi, Farhad论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJabbour, Elias论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABorthakur, Gautam论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USADiNardo, Courtney论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKonopleva, Marina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPemmaraju, Naveen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKadia, Tapan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJain, Nitin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPierce, Sherry论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAHussain, Nawar论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANing, Jing论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANogueras-Gonzalez, Graciela论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABasu, Sreyashi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USACortes, Jorge论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASharma, Padmanee论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKantarjian, Hagop论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [3] A Phase 1 Trial of Valemetostat in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S311 - S312Erba, Harry P.论文数: 0 引用数: 0 h-index: 0机构: Duke Canc Inst, Durham, NC USA Duke Canc Inst, Durham, NC USAOluwole, Olalekan O.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USA Duke Canc Inst, Durham, NC USABixby, Dale论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA Duke Canc Inst, Durham, NC USARampal, Raajit K.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Duke Canc Inst, Durham, NC USAFathi, Amir T.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Boston, MA USA Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA Duke Canc Inst, Durham, NC USAPaliwal, Prashni论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Duke Canc Inst, Durham, NC USAJin, Jin论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Duke Canc Inst, Durham, NC USAInoue, Ai论文数: 0 引用数: 0 h-index: 0机构: Daiichi Sankyo Inc, Basking Ridge, NJ USA Duke Canc Inst, Durham, NC USADaver, Naval论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Duke Canc Inst, Durham, NC USA
- [4] Survival of Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Patients Receiving Stem Cell Transplantation (SCT)BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)Nath, Rajneesh论文数: 0 引用数: 0 h-index: 0机构: Banner MD Anderson Canc Ctr, Gilbert, AZ USA Banner MD Anderson Canc Ctr, Gilbert, AZ USAReddy, Vijay论文数: 0 引用数: 0 h-index: 0机构: Actinium Pharmaceut, New York, NY, Netherlands Banner MD Anderson Canc Ctr, Gilbert, AZ USAKapur, Anil论文数: 0 引用数: 0 h-index: 0机构: Actinium Pharmaceut, New York, NY, Netherlands Banner MD Anderson Canc Ctr, Gilbert, AZ USAGebregergish, Samron论文数: 0 引用数: 0 h-index: 0机构: Ingress Hlth, Rotterdam, Netherlands Banner MD Anderson Canc Ctr, Gilbert, AZ USAGurskyte, Laura论文数: 0 引用数: 0 h-index: 0机构: Ingress Hlth, Rotterdam, Netherlands Banner MD Anderson Canc Ctr, Gilbert, AZ USAKulakova, Margarita论文数: 0 引用数: 0 h-index: 0机构: Ingress Hlth, Rotterdam, Netherlands Banner MD Anderson Canc Ctr, Gilbert, AZ USAHeeg, Bart论文数: 0 引用数: 0 h-index: 0机构: Ingress Hlth, Rotterdam, Netherlands Banner MD Anderson Canc Ctr, Gilbert, AZ USABerger, Mark S.论文数: 0 引用数: 0 h-index: 0机构: Actinium Pharmaceut, New York, NY, Netherlands Banner MD Anderson Canc Ctr, Gilbert, AZ USA
- [5] A Phase 1 Study of WU-NK-101 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)BLOOD, 2022, 140 : 12740 - 12741Cashen, Amanda F.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Sch Med, Div Oncol, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USALiu, Hongtao论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAAl Malki, Monzr M.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAZeidner, Joshua F.论文数: 0 引用数: 0 h-index: 0机构: UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAFoster, Matthew C.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAPannunzio, Angela论文数: 0 引用数: 0 h-index: 0机构: Wugen Inc, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USARamsey, Brett论文数: 0 引用数: 0 h-index: 0机构: Wugen Inc, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USABaughman, Jan论文数: 0 引用数: 0 h-index: 0机构: Alviso Clin Res, San Francisco, CA USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAMuth, John论文数: 0 引用数: 0 h-index: 0机构: Wugen, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USABakkacha, Ouiam论文数: 0 引用数: 0 h-index: 0机构: Wugen Inc, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAMcNulty, Eileen论文数: 0 引用数: 0 h-index: 0机构: Wugen Inc, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAJacobs, Kenneth论文数: 0 引用数: 0 h-index: 0机构: Wugen Inc, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USADavidson-Moncada, Jan K.论文数: 0 引用数: 0 h-index: 0机构: Wugen, St Louis, MO USA Washington Univ, Sch Med, Div Oncol, St Louis, MO USAWei, Andrew H.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia Royal Melbourne Hosp, Melbourne, Vic, Australia Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
- [6] COSTS OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) IN COLOMBIAVALUE IN HEALTH, 2022, 25 (01) : S59 - S59Lasalvia, P.论文数: 0 引用数: 0 h-index: 0机构: CUN, NeuroEconomix, Bogota, Colombia CUN, NeuroEconomix, Bogota, ColombiaGil, Rojas Y.论文数: 0 引用数: 0 h-index: 0机构: CUN, NeuroEconomix, Bogota, Colombia CUN, NeuroEconomix, Bogota, ColombiaArciniegas Moreno, K.论文数: 0 引用数: 0 h-index: 0机构: Astellas, Bogota, Colombia CUN, NeuroEconomix, Bogota, ColombiaSaturnino, Ltm论文数: 0 引用数: 0 h-index: 0机构: Astellas, Bogota, Colombia CUN, NeuroEconomix, Bogota, Colombia
- [7] Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Nunnery, Sara论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USAWang, Dorothy论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USATan, Marisela论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USAFong, Richard论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USALo, Mimi Ming论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USAOlin, Rebecca L.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USA
- [8] Sequential conditioning with high dose melphalan followed by busulfan and fludarabine in eldery patients with relapsed or refractory (r/r) acute myeloid leukemia (AML)BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 101 - 101Urbahn, M. -A.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyReicherts, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyPohlmann, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyCall, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyEsseling, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyFloeth, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyMarx, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyAlbring, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyMikesch, J. -H.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanySchliemann, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyLenz, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, GermanyStelljes, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Munster, Germany Univ Hosp Munster, Munster, Germany
- [9] Burden of relapsed/refractory (RR) acute myeloid leukemia.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Panjabi, Sumeet论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, San Francisco, CA USAHines, Dionne M.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, San Francisco, CA USAMcGuiness, Catherine Balderston论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, San Francisco, CA USAYucel, Emre论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, San Francisco, CA USAYea, Steven论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, San Francisco, CA USAMcIver, Zachariah论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, San Francisco, CA USAWade, Rolin L.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, San Francisco, CA USA
- [10] NPM1 Mutations Do Not Retain a Favorable Prognostic Impact in Adults with Advanced Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)BLOOD, 2021, 138Venugopal, Sangeetha论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAIssa, Ghayas C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKonopleva, Marina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADiNardo, Courtney D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USABorthakur, Gautam论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAJabbour, Elias J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAPemmaraju, Naveen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAYilmaz, Musa论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAShort, Nicholas J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMaiti, Abhishek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USASasaki, Koji论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMasarova, Lucia论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAPierce, Sherry A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USATakahashi, Koichi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USATang, Guilin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USALoghavi, Sanam论文数: 0 引用数: 0 h-index: 0机构: MD Anderson, Dept Hematopathol, Houston, MD USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAAndreeff, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USABhalla, Kapil N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAGarcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USARavandi, Farhad论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKantarjian, Hagop论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADaver, Naval论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA